|
 August 2021 - Neurotechnology and responsible innovation
Issue editor: Françoise ROURE,
associate researcher at CETCOPRA, a laboratory of Paris 1 Panthéon-Sorbonne University and president of Security and Risks at the Conseil Général de l’Économie
and
Laure TABOUY
Paris Saclay University ‒ Espace Éthique de l’APHP, Faculty of Medicine, Paris, and Digital and Ethics Biotech, Paris
Introduction: Laure TABOUY and Françoise ROURE
From academic and industrial explorations toward new therapeutic, technical and industrial applications
Neurotechnology at the OECD: The role of the private sector in governance
By David WINICKOFF
Organisation for Economic Cooperation and Development
The convergence of artificial intelligence and neurotechnology: A reality and a desirable future?
Alexis Génin,
Institut du Cerveau (ICM)
Learning how to control a brain-computer interface: BrainConquest
Fabien Lotte, Aurélien Appriou, Camille Benaroch, Pauline Dreyer, Alper Er, Thibaut Monseigne, Léa Pillette, Smeety Pramij, Sébastien Rimbert and Aline Roc,
INRIA Bordeaux Sud-Ouest, LaBRI (CNRS, Bordeaux University, Bordeaux INP), Talence
Why and how to boost sharing in neuroimagery?
Michel Dojat,
director of research, INSERM, Grenoble Institute of Neurosciences
Neurotechnology in relation to health, well-being, security and performance
Which strategic brain images could speed up advances in clinical research?
Jean-François Mangin,
Paris-Saclay University, CEA, CNRS, Baobab, Neurospin
Neurofeedback: The pervasive development of applications in neurotechnology for managing stress, attention disorders and pain
Yohan Attal,
president of myBrain Technologies
Nudge, neurotechnology and neuromarketing: The state of the art and feedback on the announced potentials and their limits
Éric Singler,
CEO BVA Nudge Unit
Responsible innovations in neurotechnology: Societal, ethical and legal issues
The task force for a responsible development of neurotechnology in France
Hervé Chneiweiss,
neurobiologist and neurologist, director of research at the CNRS, head of the laboratory Neuroscience Paris Seine ‒ CNRS/INSERM/Sorbonne University
For a responsible development of neurotechnology in France: The task force’s work
Pascal Maigné,
Ministry of Higher Education, Research and Innovation and the French delegation to the Working Party on Biotechnology, Nanotechnology and Converging Technologies (BNCT) at the OECD
Neuroscience and the law on bioethics
Claude Delpuech,
INSERM,
and
Pierre-Henri Duée,
National Advisory Committee on Ethics for the Life and Health Sciences
A simplified ‟vision” transmitted from the skin to the brain: Feedback on the Sixth Sense
Amaury Buguet
and
Rémi Du Chalard,
Artha France
Is neurotechnology dualistic?
Bernard Poulain,
director of research at the CNRS, researcher in neurobiology at the Institut des Neurosciences Cellulaires et Intégratives in Strasbourg
The epistemological questions raised by neuro-science and innovations in neurotechnology
Françoise Roure,
associate researcher at CETCOPRA, a laboratory of Paris 1 Panthéon-Sorbonne University and president of Security and Risks at the Conseil Général de l’Économie
The ethical and legal issues raised by research in neurotechnology and for neuroscientists, firms and society
Laure Tabouy,
Paris Saclay University ‒ Espace Éthique de l’APHP, Faculty of Medicine, Paris, and Digital and Ethics Biotech, Paris
|
